Eli Lilly, Boehringer Ingelheim’s Jardiance clinches heart failure edge with FDA nod for wider label fkansteiner Thu, 02/24/2022 – 14:11 More: Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label Source: fierce
read moreTeva, Endo and more back on the hook in San Francisco opioid trial fkansteiner Thu, 02/24/2022 – 11:23 More: Teva, Endo and more back on the hook in San Francisco opioid trial Source: fierce
read moreMerck KGaA pledges $550M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead kdunleavy Thu, 02/24/2022 – 11:20 More: Merck KGaA pledges 0M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead Source: fierce
read moreGlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval aliu Thu, 02/24/2022 – 11:17 More: GlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval Source: fierce
read moreBioMarin eyes first profits in 2022 as dwarfism drug launch kicks into gear, hemophilia gene therapy refiling nears aliu Thu, 02/24/2022 – 10:12 More: BioMarin eyes first profits in 2022 as dwarfism drug launch kicks into gear, hemophilia gene therapy
read moreNo sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial More: Data from first DMT-assisted clinical trial revealed Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals